Cargando…
LPS combined with CD47mAb enhances the anti‑osteosarcoma ability of macrophages
Macrophages are abundant in tumor tissues, and they affect the biological properties of tumor cells. The present findings indicated that osteosarcoma (OS) has a high proportion of tumor-promoting M2 macrophages. The CD47 protein can aid tumor cells in their immunological escape. It was identified th...
Autores principales: | Yuan, Peng, Que, Yukang, Liu, Yulei, He, Peng, Guo, Zehao, Hu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091190/ https://www.ncbi.nlm.nih.gov/pubmed/37065782 http://dx.doi.org/10.3892/ol.2023.13777 |
Ejemplares similares
-
Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
por: Mohanty, Suchismita, et al.
Publicado: (2019) -
Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
por: Zhang, Jingzhe, et al.
Publicado: (2019) -
State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017) -
SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023) -
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)